Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about AGNPF Recent news which mentions AGNPF Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Tickers AGNPF ATAI CMND CMPS Tags ENVB PSIL Market News From Benzinga DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design April 03, 2024 Tickers AGNPF Tags Human Stroke DMT/Assisted Therapy Cannabis From Benzinga Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 Tickers AGNPF ATAI AWKNF CMPS Tags OPTHF Markets ENVB From Benzinga DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study August 08, 2023 Tickers AGNPF Tags News Benzinga Psychedelics From Benzinga DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up June 05, 2023 Tickers AGNPF Tags Benzinga Psychedelics AGN Neuro From Benzinga How To Finance A Psychedelics Business? Learn From These Four Companies April 04, 2023 Tickers AGNPF CMND PSYGF Tags Psychedelic/Assisted Therapies Financing Diamond Therapeutics Inc/ From Benzinga Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment April 04, 2023 Tickers AGNPF Tags AGNPF Markets Market News From Benzinga Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More March 07, 2023 Tickers AGNPF AWKNF BRAXF CMPS Tags BRAXF PSIL Market News From Benzinga Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI March 03, 2023 Tickers AGNPF Tags contributors Market News Benzinga From Benzinga Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program March 01, 2023 Tickers AGNPF IPOS Tags Psychedelics Benzinga IPOs From Benzinga Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More February 27, 2023 Tickers AGNPF AWKNF CMND CYBN Tags Market News Markets CMND From Benzinga Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More February 21, 2023 Tickers AGNPF AWKNF CYBN DMTTF Tags Psychedelics IWINF CYBN From Benzinga Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program February 21, 2023 Tickers AGNPF TBI Tags Legal General Management From Benzinga Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose February 16, 2023 Tickers AGNPF Tags AGNPF Markets Cannabis From Benzinga A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing January 18, 2023 Tickers AGNPF DMT Tags Human Stroke Psychedelic/Assisted Therapies Psychedelics From Benzinga Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One January 03, 2023 Tickers AGNPF Tags Cannabis Market News Markets From Benzinga EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans December 15, 2022 Tickers AGNPF ATAI FLHLF Tags Benzinga Benjamin Lightburn Management From Benzinga Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More November 21, 2022 Tickers AGNPF BMNDF CMND CMPS Tags MYCOF TSLA Markets From Benzinga Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon November 16, 2022 Tickers AGNPF Tags DMT Clinical Trial Psychedelics Benzinga From Benzinga Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University October 24, 2022 Tickers AGNPF Tags depression News Penny Stocks From Benzinga A Foundational Study On Stroke Is Ready. Here Is Why It's Important September 12, 2022 Tickers AGNPF DMT Tags Global Contracts Market News From Benzinga Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment September 08, 2022 Tickers AGNPF Tags Stroke Benzinga Psychedelics From Benzinga Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution August 23, 2022 Tickers AGNPF Tags GRA Enterprises Benzinga Psychedelics From Benzinga Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study July 18, 2022 Tickers AGNPF Tags Biotech Benzinga Penny Stocks From Benzinga Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 Tickers AGNPF ALID ATAI AWKNF Tags GHRS SILO FLHLF From Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Tickers AGNPF ALID ATAI AWKNF Tags EHVVF TRIP NMDBF From Benzinga Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics September 13, 2021 Tickers AGNPF ALID ATAI FTRP Tags AGNPF Octarine Bio Markets From Benzinga Investors Should Avoid High-Risk Atossa Therapeutics August 02, 2021 Tickers AGNPF ATOS GILD LLY Tags NASDAQ:ATOS, NYSE:LLY,OTC:AGNPF,NASDAQ:SRNE,NASDAQ:GILD Stocks to Sell SRNE From InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.